New Diamond Discovery Possible in Canada's North VANCOUVER,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
New Diamond Discovery Possible in Canada's North

VANCOUVER, British Columbia, July 23, 2014 (GLOBE NEWSWIRE) -- Diamond explorer North Arrow Minerals (TSX-V: NAR ) is set to commence its first drill program with partner Arctic Star Exploration at Redemption, a project located in the famed Lac De Gras diamond district, currently home to three of the world's largest diamond mines: Dominion's Ekati, Rio Tinto's Diavik, and De Beers' Snap Lake.

North Arrow knows the Lac De Gras region perhaps better than any other currently assembled diamond exploration team. The company's Chairman, Gren Thomas, made the world-class discovery of the Diavik Diamond Mine just 32 kilometers from where drilling at the Redemption will take place. Diavik is currently the 5 th largest diamond mine in the world estimated to produce $787 million worth of diamonds in 2014.

Thomas, an inductee in the Canadian Mining Hall of Fame, discovered Diavik with the same pragmatic prospecting philosophy that the North Arrow team is utilizing at Redemption –explore the least trafficked land in the closest proximity to the largest and most economic diamond deposit in world. In an exclusive interview with Financial Press , North Arrow's Thomas explained, "The exciting thing about Redemption…in looking for a new diamond deposit near Diavik is yes, you already know you're in the right area geologically; the rocks have been proven, but the other thing is you don't have to find another Diavik. You have the existing mine infrastructure nearby already. You don't necessarily have to find a standalone mine. This has a real impact on lowering your threshold for a new discovery."

North Arrow President and CEO Ken Armstrong noted that he sees particular prospective appeal in Redemption as it hosts the Coppermine train, which is "one of the last well-defined and un-sourced kimberlite indicator mineral (KIM) trains in the Lac de Gras region." KIM trains are common in terrains where a glacier advanced over a kimberlite pushing and dispersing the kimberlite material in the path that the glacier traveled. As the glacier melted, the train was left in place, in essence creating a trail to the kimberlite. The discoveries of Diavik and Ekati, as well as world-class diamond discoveries in Russia's arctic have been identified using a similar technique. 

Kimberlite pipes are geological formations that serve as the primary source of mined diamonds. 

Prior to North Arrow's involvement in the project, Redemption had over C$13 million invested in exploration with over 3,100 till samples taken and 10 airborne geological surveys conducted on the property. Given all of the exploration dollars spent on the project, there have only been approximately 20 holes drilled, and a lot of the past drilling encountered logistical complications failing to provide a true indication of the targets potential. The history of Redemption presents an optimal opportunity for recently financed North Arrow to step in as project operator.

In July of last year, North Arrow entered into an earn-in agreement with Arctic Star, where North Arrow has the option to spend C$5 million by July 2017 to earn a 55% interest in the rights to Redemption. By the completion of the current drill program, North Arrow will have already spent approximately C$2 million towards the earn-in.

With the help of new geophysical technology and advanced mineral chemistry that did not exist during the last diamond rush in Canada following the discovery of Ekati and Diavik over 15 years ago, North Arrow has singled out 6 to 8 "high-priority" targets to drill, totaling 1000 meters. Any kimberlite discovery in the Coppermine train could be a big boost for North Arrow shareholders. Armstrong notes hitting kimberlite for the first time in the Coppermine train would "provide validation of our business plan." Given the indicator minerals found in the train, there is good reason to believe that if kimberlite is identified it will bear diamonds. 

According to De Beers, only 6,400 kimberlite pipes have been discovered in the world, of those only approximately 900 have been classified as diamond bearing, and of those just about 100 have been economic enough to mine. This past November North Arrow stock surged 40% after the company announced that its exploration efforts led to a diamond bearing kimberlite discovery at its Pikoo property in Saskatchewan.  

The North Arrow drill team arrived at the Redemption camp late last week and the drilling program is set to run through the middle of August. Results from the program can be expected shortly after drilling is complete, if not before --if kimberlite is hit, the results may be considered material and would merit an imminent press release.

In addition to Redemption, North Arrow shareholders also enthusiastically await results from one of the company's Nunavut projects, Qilalugaq, where results from a bulk sample are expected in early 2015. The results from the bulk sample could be a game changer for the company, as Armstrong notes "strong results from the sample could take North Arrow from an exploration company to a developer."

North Arrow is one of the few pure diamond exploration companies in the world today just as a boost in new demand for diamonds is forecast to outpace new supply. Russia's Grib mine, which started production last month, will be the first new non-alluvial diamond mine to produce more than 1 million carats per year since Diavik came online in 2003. 

New global demand for diamonds is primarily coming out of China, where the current generation is the first to adopt the Western tradition of giving diamond engagement rings. The number of urban Chinese brides being given a diamond engagement ring has increased from less than 1% to greater than 50% over the last 20 years; half of China's population of 1.3 billion is considered urban.

North Arrow is just off of its 52-week high of C$0.84 closing at C$0.81 on July 18 th . The stock trades close to 100k shares a day on the Toronto Venture exchange under the symbol NAR, and NAHWF in the U.S.

Legal Disclaimer/Disclosure: A fee has been paid for the production and distribution of this Report. This document is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. No information in this article should be construed as individualized investment advice. A licensed financial advisor should be consulted prior to making any investment decision. Financial Press makes no guarantee, representation or warranty and accepts no responsibility or liability as to its accuracy or completeness. Expressions of opinion are those of the authors only and are subject to change without notice. Financial Press assumes no warranty, liability or guarantee for the current relevance, correctness or completeness of any information provided within this article and will not be held liable for the consequence of reliance upon any opinion or statement contained herein or any omission. Furthermore, we assume no liability for any direct or indirect loss or damage or, in particular, for lost profit, which you may incur as a result of the use and existence of the information, provided within this article.

Also, please note that republishing of this article in its entirety is permitted as long as attribution and a back link to FinancialPress.com are provided. Thank you.

North Arrow Minerals Suite 960 - 789 West Pender Street Vancouver, BC - Canada - V6C 1H2 Tel: +1.604.668.8355 Fax: +1.604.336.4813

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 241

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 431

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 212

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 210

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

Brixton Metals Delivers Promising Drill Results in Thorn Project

Updated Category News Views 167

Brixton Metals' Latest Drill Results Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) recently unveiled its second batch of drill results from the 2025 exploration season. The company operates the Thorn Project, an underexplored district known for its potential in copper-gold porphyry deposits. Highlighting Impressive Assay Results The recent drilling at the...

Continue Reading
US Labor Market Stagnation: A Closer Look at 2025 Trends

Updated Category News Views 275

November Layoffs and Hiring Trends In November, layoffs by U.S. employers reduced significantly, signaling a shift in the job market dynamics. Yet, companies are still hesitant to recruit new employees, indicating a labor market that remains restrained due to various pressures. Businesses are facing challenges such as soft demand, tariff implications, and soaring...

Continue Reading
Dollar Steady Amid Global Market Uncertainty and Yuan Weakness

Updated Category News Views 127

Asian Currency Markets React to U.S. Dollar Strength In the bustling arena of Asian currencies, the atmosphere is charged with anticipation as investors monitor the situation in China regarding potential economic stimulus measures. Meanwhile, the U.S. dollar is exhibiting remarkable strength, currently hovering near a two-and-a-half month high. This rise comes in light of...

Continue Reading
Understanding Recent Insider Trades at Omega Healthcare Invts

Updated Category News Views 75

Examining Insider Trades at Omega Healthcare Invts Recently, a notable insider trade involving Omega Healthcare Invts has drawn attention. Chief Operating Officer Daniel Booth executed a significant transaction, selling 56,725 shares as disclosed through an SEC filing. This particular sale took place on a recent date and revealed a total transaction value of $2,283,181....

Continue Reading
Exploring Future Growth in Healthcare Digital Payments Market

Updated Category News Views 150

Introduction to Digital Payments in Healthcare The transformation in the realm of healthcare is not just about treatments and services; it extends deeply into how payments are managed. The Digital Payment in Healthcare Market is evolving, with an anticipated growth in value reaching USD 61,521.8 Million by the year 2033. This incredible increase is projected to occur at a...

Continue Reading